Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Stem cells

Stem cells tackle diabetes

Stem cells may be useful for treating type 2 diabetes, according to a study in mice.

Insulin-producing cells derived from human embryonic stem cells reduce blood sugar levels in mice with type 1 diabetes, but it was unclear whether the approach would work for type 2 diabetes, which is much more common in humans. To model the disease, Timothy Kieffer of the University of British Columbia in Vancouver, Canada, and his colleagues fed mice a high-fat diet. After five days, the mice had high blood glucose levels, and by seven weeks they exhibited other symptoms of type 2 diabetes.

Transplanting pancreatic cells grown from human embryonic stem cells into these mice increased their sensitivity to insulin. When combined with diabetes drugs, the transplants also reduced obesity and blood sugar levels.

Stem Cell Rep. (2015)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stem cells tackle diabetes. Nature 519, 392 (2015).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing